微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.24% | -23.88% | -66.43% | 16/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 12.63% | -26.14% | -18.04% | 16/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 15.41% | 5.33% | 41.51% | 3/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 10.89% | 8.47% | 95.51% | 5/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 5.57% | 85.67% | -67.43% | 8/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 17.1% | 100.7% | 16.88% | 8/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 14.63% | 209.96% | 45.72% | 10/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 10.04% | 350.22% | 234.67% | 7/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3% | 175.23% | -64.79% | 35/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.52% | 91.03% | 80.51% | 37/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.72% | 61.64% | 111.66% | 74/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.23% | 253.97% | 104.59% | 79/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.09% | 23.86% | -75.56% | 85/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.46% | -38.4% | 52.74% | 77/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.92% | -47.2% | 363.49% | 86/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.63% | -85.04% | -28.41% | 106/157 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.88% | -77.2% | -87.85% | 96/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.24% | -31.11% | 30.92% | 64/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 5.53% | 41.43% | 31.35% | 73/157 | 4.46% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 4.21% | 16.3% | 9.07% | 66/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.86% | 467.65% | -63.27% | 22/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.51% | 98.68% | 190.33% | 49/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 3.62% | 52.74% | -31.57% | 67/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-12-31 | 5.29% | 16.78% | 35.29% | 83/157 | 2.57% | 中哲精化 | 45.32% | 行业排名> |
| 2019-09-30 | 3.91% | -56.07% | 64.98% | 77/157 | 7.58% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 2.37% | -70.08% | 248.53% | 76/157 | 5.02% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-03-31 | 0.68% | 288.89% | -84.99% | 89/157 | 2.45% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 4.53% | -68.74% | -49.1% | 89/157 | 7.16% | 奥赛康 | 28.15% | 行业排名> |
| 2018-09-30 | 8.9% | 2% | 12.37% | 32/157 | 7.21% | 宏源药业 | 21.91% | 行业排名> |
| 2018-06-30 | 7.92% | 115.8% | 2300% | 15/157 | 4.63% | 奥赛康 | 9.7% | 行业排名> |
| 2018-03-31 | -0.36% | 2% | -102.48% | 93/157 | 2.57% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 14.49% | 116.16% | 294.82% | 27/157 | 9.62% | 信立泰 | 25.93% | 行业排名> |
| 2017-06-30 | 3.67% | 113.93% | 104.09% | 64/157 | 5.56% | 昂利康 | 15.91% | 行业排名> |
| 2016-12-31 | -89.67% | 2% | -240.3% | 109/157 | 6.05% | 奥赛康 | 12.08% | 行业排名> |
| 2016-06-30 | -26.35% | 2% | 2% | 88/157 | 3.52% | 一品红 | 31.62% | 行业排名> |